GlassScriptPhysician profile
Brandon Dean Wilde
NPI 1407169865
$512.77
in general payments reported to CMS, 2019-2025
15 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2021: $12.66 · 2022: $14.05 · 2023: $14.79 · 2024: $123 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $116.52 | 2025 | Bun-Yo-Matic |
| Wright Medical Technology, INC. | $93.28 | 2019 | |
| Integra Lifesciences Corporation | $57.77 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $41.80 | 2021-2024 | Puraply Am |
| Smith+Nephew, INC. | $39.33 | 2024-2025 | Grafix Pl, Stravix |
| Orthofix Medical, INC. | $23.72 | 2025 | Accelstim |
| Djo, LLC | $21.40 | 2025 | Cmf |
| Averitas Pharma INC. | $18.11 | 2024 | Qutenza |
| Kerecis Limited | $16.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $16.49 | 2019 | |
| Ani Pharmaceuticals, INC. | $15.63 | 2025 | Purified Cortrophin Gel |
| Curonix LLC | $14.79 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $14.05 | 2022 | |
| Boston Scientific Corporation | $11.64 | 2019 | |
| Merck Sharp & Dohme LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Wilde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.